- Paediatric long QT syndrome: clinical outcomes and therapy in the Spanish National Registry
- Late INa as a Therapeutic Target: New Strategies, Computational Modelling, Drug Development, and Clinical Translation
- Age at Menarche and the Risk of Cardiac Events in Women With Congenital Long QT Syndrome
- Roles of myeloperoxidase and the AMPK/PI3K/AKT/eNOS pathway in osimertinib-induced cardiotoxicity: multilevel evidence from disequilibrium analysis, network pharmacology, mendelian randomization, and animal experiments
- The infero-apical left ventricular aneurysm and long QT syndrome caused by mutation delKKP 1504-1506 in SCN5A gene
- Cardiac Arrest in a Young Soccer Player With a Pathogenic SCN5A Variant
- Multimodality Risk Stratification in Athletes With Long QT Syndrome
- Case Report: Lurasidone-Induced Type 2 Brugada Pattern in a Pediatric Patient
- Charged to death: Energy drinks, smart drugs, and sudden cardiac death
- Perioperative anesthetic management and procedural sedation in a child with type 1 congenital long QT Syndrome undergoing serial procedures: a case report
- Bisoprolol Treatment and Adherence in Pediatric Patients With Genotype-Positive Long QT Syndrome
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- SLLD: Single-lead ECG LQTS detection framework based on knowledge distillation
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1
- Beta-Blockers and Exercise Performance in Children with Long QT Syndrome
- Multicenter real world validation of on device single lead ECG parameters for remote cardiac assessment
- Case Report: A novel MYBPC3 gene variant in a Chinese patient with hypertrophic cardiomyopathy and apical ventricular aneurysm, with a concurrent novel KCNJ5 gene variant
- Genotype-Specific Electrophysiological Remodeling in PLN R14del Cardiomyopathy: Implications for Precision Antiarrhythmic Therapy
- Practical management of drug-induced long QT syndrome
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Atrial Flutter-Triggered Ventricular Tachycardia Storm in Gitelman Syndrome: A Case Report
- An Unusual Genetic Variant of Long QT Syndrome with Late Presentation in the Sixth Decade
- How to Replace the TQT Study-The Use of Concentration-QTc Modeling to Exclude a Small Effect of a Novel Drug on QT Interval: Historical Perspective and Implementation
- Circadian Pattern of Ventricular Fibrillation-Terminating Shocks among Patients with Diagnosed and Treated Congenital Long QT Syndrome
- Assessing the risk of drug-induced corrected QT interval prolongation in primary care
- Combined Leadless Pacing and Subcutaneous ICD Therapy in Long QT Syndromes
- Prominent T-wave induced by Valsalva maneuver associated with a RYR2 loss-of-function variant
- Jervell and Lange-Nielsen Syndrome Related Clinical Genetics and Experimental Models
- Polymorphic ventricular tachycardia with mutation in KCNJ2: case report
- hERG1 channels and potential therapeutics for long QT syndrome
- Electrocardiographic Repolarization Changes Following Orchiectomy: Insights Into QT Interval Prolongation and Clinical Implications
- Case Report: Nadolol-mexiletine combination therapy for refractory neonatal long QT syndrome: a case series beyond sodium channelopathies
- Multisystemic Assessment in Andersen-Tawil Syndrome: Report of Eighteen Individuals
- Rare pathogenic mutation of KCNH2 p.D501N associated with early-onset malignant long QT syndrome
- Off-Target Inhibition of PKA RII by Crizotinib Leads to Reduced hERG Expression and Acquired QT Prolongation
- Spectrum of potentially lethal cardiac conditions presenting with fetal sinus bradycardia: a report on 34 cases
